GNH USA

Europe — EMA

Methotrexate Pfizer Healthcare Ireland

GNH USA supplies Methotrexate Pfizer Healthcare Ireland (Methotrexate), a disease-modifying antirheumatic drug for rheumatoid arthritis, psoriasis, leukemia

Methotrexate

Request sourcing

1
Pack/s

What is Methotrexate?

Methotrexate, the active ingredient in Methotrexate Pfizer Healthcare Ireland, is an antimetabolite presented as a sterile solution for injection for intraarterial, intramuscular, intrathecal use. It treats rheumatoid arthritis, psoriasis, acute lymphoblastic leukemia and non‑Hodgkin lymphoma in appropriate patients.

GNH USA supplies Methotrexate Pfizer Healthcare Ireland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Methotrexate used for?

Methotrexate is an antimetabolite DMARD used across autoimmune and oncologic disease pathways.

- Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: improves skin lesions and decreases plaque formation. - Acute lymphoblastic leukemia: interferes with malignant cell proliferation leading to remission. - Non‑Hodgkin lymphoma: induces tumor cell death and contributes to disease control.

What are the side effects of Methotrexate?

Methotrexate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea and vomiting. - Fatigue and malaise. - Oral ulceration or mucositis. - Mild elevation of liver enzymes. - Transient cytopenia. - Mild alopecia.

Serious or Rare Side Effects: - Severe liver toxicity or fibrosis. - Pulmonary fibrosis or interstitial pneumonitis. - Severe bone marrow suppression leading to pancytopenia. - Acute renal failure. - Severe cutaneous reactions such as Stevens‑Johnson syndrome. - Opportunistic infections due to immunosuppression.

What precautions apply to Methotrexate?

Before initiating therapy, clinicians should assess patient-specific risk factors and monitor laboratory parameters.

- Renal function: assess baseline and monitor during therapy. - Liver function: perform regular liver enzyme tests. - Hematologic monitoring: complete blood count before and during treatment. - Pregnancy: avoid use; contraindicated in pregnancy. - Drug interactions: review concomitant medications for potential interactions. - Store at ambient temperature: keep in original container, protect from moisture and light.

What does Methotrexate interact with?

Methotrexate interacts with several drug classes; careful review is essential.

Major Interactions (Avoid): - Nonsteroidal anti‑inflammatory drugs (NSAIDs): increase methotrexate toxicity. - Proton pump inhibitors (e.g., omeprazole): may raise serum methotrexate levels. - Trimethoprim‑sulfamethoxazole: risk of severe bone‑marrow suppression.

Moderate Interactions (Monitor Closely): - Azathioprine: additive immunosuppression. - Live vaccines: heightened risk of infection. - Penicillins: may affect renal clearance of methotrexate.

Frequently asked questions

What conditions is Methotrexate used to treat?+
Methotrexate is prescribed for several serious conditions, including rheumatoid arthritis, psoriasis, acute lymphoblastic leukemia and non‑Hodgkin lymphoma. In each case it works to reduce disease activity, control symptoms and improve patient outcomes when used as part of a comprehensive treatment plan.
How does Methotrexate work in the body?+
Methotrexate blocks the enzyme dihydrofolate reductase, which is essential for making tetrahydrofolate. This limits the synthesis of DNA, RNA and proteins, especially in rapidly dividing cells such as cancer cells and activated immune cells, thereby reducing inflammation and tumor growth.
What is the usual dose of Methotrexate?+
The specific dose of Methotrexate is determined by the prescribing clinician based on the patient’s condition, weight, renal function and treatment goals. Dosage regimens can vary widely, and the prescriber will tailor the schedule to achieve the best therapeutic effect while minimizing risk.
Is Methotrexate safe to use during pregnancy or while breastfeeding?+
Methotrexate is contraindicated in pregnancy because it can cause fetal malformations and miscarriage. It is also not recommended while breastfeeding, as it may be excreted in breast milk and affect the infant. Women of child‑bearing potential should use effective contraception during treatment and for a period after discontinuation.
How do I order Methotrexate Pfizer Healthcare Ireland from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.
How does Methotrexate compare with other DMARDs or biologic therapies?+
Methotrexate is a conventional synthetic DMARD that is often used as a first‑line agent because of its broad efficacy and lower cost compared with biologic therapies such as TNF‑α inhibitors. Biologics target specific cytokines and may be chosen when patients do not respond adequately to methotrexate or experience intolerable side effects.
What are the storage and handling requirements for Methotrexate?+
Methotrexate should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Ensure the container is tightly closed and keep it out of reach of children. Do not freeze the product.
How is Methotrexate administered to patients?+
Methotrexate is supplied as a sterile injectable solution and can be given via intra‑arterial, intramuscular or intrathecal routes, depending on the indication and clinical protocol. Administration is performed by a qualified healthcare professional under aseptic conditions.
What are the most serious risks associated with Methotrexate therapy?+
The most serious adverse events include severe liver toxicity, pulmonary fibrosis, profound bone‑marrow suppression leading to pancytopenia, acute renal failure, and life‑threatening cutaneous reactions such as Stevens‑Johnson syndrome. Patients should be monitored regularly for early signs of these complications.
Who should not use Methotrexate?+
Methotrexate is contraindicated in pregnant women, individuals with severe renal or hepatic impairment, and patients with known hypersensitivity to the drug. It should also be avoided in patients with active infections or those receiving certain interacting medications without close monitoring.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Methotrexate
Route
Intraarterial Use , Intramuscular Use , Intratheca
Manufacturer
Pfizer Healthcare Ireland Unlimited Company
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU